Development action with informed and engaged societies
After nearly 28 years, The Communication Initiative (The CI) Global is entering a new chapter. Following a period of transition, the global website has been transferred to the University of the Witwatersrand (Wits) in South Africa, where it will be administered by the Social and Behaviour Change Communication Division. Wits' commitment to social change and justice makes it a trusted steward for The CI's legacy and future.
 
Co-founder Victoria Martin is pleased to see this work continue under Wits' leadership. Victoria knows that co-founder Warren Feek (1953–2024) would have felt deep pride in The CI Global's Africa-led direction.
 
We honour the team and partners who sustained The CI for decades. Meanwhile, La Iniciativa de Comunicación (CILA) continues independently at cila.comminitcila.com and is linked with The CI Global site.
Time to read
less than
1 minute
Read so far

Pandemic Influenza: A Global Perspective

0 comments
Affiliation
WHO Global Influenza Programme
Summary

This presentation was delivered by Klaus Stöhr of the World Health Organization (WHO) at the conference 'Vaccine Production: Potential Engineering Approaches to a Pandemic,' held in April 2006 in Cleveland, Ohio, United States. The presentation discusses the possible implications of an outbreak of pandemic influenza, including how it will affect community services and possibly result in social and political disruptions, as well as economic losses. It particularly explores the possibility of an avian influenza (also know as avian flu or bird flu) outbreak. It mentions that 150 countries have reported that they have preparedness plans, but less than 50 countries have published pandemic preparedness plans. A preparedness plan consists of strategies around the health service response, public health response, communications, surveillance and information gathering, and leadership, organisation and co-ordination.

The presentation discusses the possibilities and challenges with stockpiling antivirals. It also discusses how timely and equitable access to safe and effective influenza pandemic vaccines will depend on the efficiency of the production phase. Research is needed to support vaccine production, as well as a central laboratory facility for serological testing. Post-marketing surveillance/pharmo-vigilance recommendations will need to b e developed. According to the presentation, vaccines and antivirals will not be available for the majority of the world population. National pandemic preparedness can reduce health impact and social and economic disruption.